Total Funding
37
Total FundingSeries C raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
52465
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Mike Grey: President & CEOPast Role: Lumena Pharmaceuticals, President & CEO
Past Role: Adastra Pharmaceuticals, Co-Founder & Chief Business Officer
Pfizer
About the Company
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and
life-threatening diseases that affect people with compromised immune systems.
Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
